Skip to main content
Clinical Trials/NCT05571709
NCT05571709
Recruiting
Not Applicable

Does an Acute Exercise Bout Increases Soluble and Muscle Myokine Concentration in Healthy, Older Persons

Hasselt University1 site in 1 country20 target enrollmentSeptember 15, 2022
ConditionsAgingExercise

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Aging
Sponsor
Hasselt University
Enrollment
20
Locations
1
Primary Endpoint
Cytokine concentration
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

The incidence of age-related diseases, such as cancer and cardiovascular diseases, rapidly rises. These days, age-related diseases cause the majority of all healthcare expenses. During ageing senescent cells secrete a range of harmful inflammatory signals, which leads to chronic inflammation (inflamm-aging) and accelerates aging throughout the rest of the body. Interestingly, people who regularly exercise show less signs of inflamm-aging compared to people with a sedentary lifestyle. Molecules secreted by skeletal muscles, called myokines, may play an important role. However, the underlying molecular mechanisms remain unknown. This pilot study aims to investigate if an acute bout of resistance training is an appropriate tool to induce an increase in the release of muscle derived myokines in aged persons.

Registry
clinicaltrials.gov
Start Date
September 15, 2022
End Date
December 31, 2023
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Hasselt University
Responsible Party
Principal Investigator
Principal Investigator

Niels Hellings

Professor Doctor

Hasselt University

Eligibility Criteria

Inclusion Criteria

  • Healthy persons

Exclusion Criteria

  • Infection \< 2 weeks ago
  • Received a vaccine \< 2 weeks ago
  • Allergy to Lidocain
  • Immune deficiency
  • Presence of a tumour or in treatment
  • Usage of anti-coagulant medication
  • Presence of following conditions:
  • Haemophilia
  • Auto-immune disease
  • Cardiovascular disease

Outcomes

Primary Outcomes

Cytokine concentration

Time Frame: Day 2

Measurement of multiple cytokines in blood (for example: IL-6, IL-15, IL-4, irisin...) with ELISA's or multiplex assays

Myokine production

Time Frame: Day 2

Immunohistochemistry staining (fluorescent) of multiple myokines (for example: IL-6, IL-15, IL-4, irisin..) and aging markers (p16,p21...) on muscle tissue

Myokine protein levels

Time Frame: Day 2

Western blotting of multiple myokines in muscle tissue

Myokine gene expression

Time Frame: Day 2

Quantitative PCR (polymerase chain reaction) of markers in muscle tissue

Immune parameters

Time Frame: Day 2

Flow cytometry panels of immune parameters in muscle tissue

Secondary Outcomes

  • Resting Heart Rate(Day 1)
  • Blood pressure(Day 1)
  • International Physical Activity Questionnaire (Short form)(Day 1)

Study Sites (1)

Loading locations...

Similar Trials